Cargando…
Live Cell Imaging Supports a Key Role for Histone Deacetylase as a Molecular Target during Glioblastoma Malignancy Downgrade through Tumor Competence Modulation
Glioblastoma (GBM) is the most aggressive tumor of the central nervous system, and the identification of the mechanisms underlying the biological basis of GBM aggressiveness is essential to develop new therapies. Due to the low prognosis of GBM treatment, different clinical studies are in course to...
Autores principales: | Menezes, Aline, dos Reis, Gustavo Henrique, Oliveira-Nunes, Maria Cecília, Mariath, Fernanda, Cabanel, Mariana, Pontes, Bruno, Gonçalves Castro, Newton, de Brito, José Marques, Carneiro, Katia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720048/ https://www.ncbi.nlm.nih.gov/pubmed/31531023 http://dx.doi.org/10.1155/2019/9043675 |
Ejemplares similares
-
Epigenetic Control of Macrophage Shape Transition towards an Atypical Elongated Phenotype by Histone Deacetylase Activity
por: Cabanel, Mariana, et al.
Publicado: (2015) -
Galectin-3, histone deacetylases, and Hedgehog signaling: Possible convergent targets in schistosomiasis-induced liver fibrosis
por: de Oliveira, Felipe Leite, et al.
Publicado: (2017) -
The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020) -
The downgrading of pain sufferers’ credibility
por: Tosas, Mar Rosàs
Publicado: (2021) -
Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)